Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP238750.RAb8E3ddWewnE1DhCeA3hU5yxSDdawLK0KYReWyZ9cxrc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP238750.RAb8E3ddWewnE1DhCeA3hU5yxSDdawLK0KYReWyZ9cxrc130_assertion type Assertion NP238750.RAb8E3ddWewnE1DhCeA3hU5yxSDdawLK0KYReWyZ9cxrc130_head.
- NP238750.RAb8E3ddWewnE1DhCeA3hU5yxSDdawLK0KYReWyZ9cxrc130_assertion description "[The AdCEACD/5-FC system may become a new, potent and specific approach for the gene therapy of CEA-positive neoplasms, especially colon carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP238750.RAb8E3ddWewnE1DhCeA3hU5yxSDdawLK0KYReWyZ9cxrc130_provenance.
- NP238750.RAb8E3ddWewnE1DhCeA3hU5yxSDdawLK0KYReWyZ9cxrc130_assertion evidence source_evidence_literature NP238750.RAb8E3ddWewnE1DhCeA3hU5yxSDdawLK0KYReWyZ9cxrc130_provenance.
- NP238750.RAb8E3ddWewnE1DhCeA3hU5yxSDdawLK0KYReWyZ9cxrc130_assertion SIO_000772 11925606 NP238750.RAb8E3ddWewnE1DhCeA3hU5yxSDdawLK0KYReWyZ9cxrc130_provenance.
- NP238750.RAb8E3ddWewnE1DhCeA3hU5yxSDdawLK0KYReWyZ9cxrc130_assertion wasDerivedFrom befree-20140225 NP238750.RAb8E3ddWewnE1DhCeA3hU5yxSDdawLK0KYReWyZ9cxrc130_provenance.
- NP238750.RAb8E3ddWewnE1DhCeA3hU5yxSDdawLK0KYReWyZ9cxrc130_assertion wasGeneratedBy ECO_0000203 NP238750.RAb8E3ddWewnE1DhCeA3hU5yxSDdawLK0KYReWyZ9cxrc130_provenance.